The blood-based test by Astrin Biosciences shows high sensitivity and specificity across cancer stages and subtypes, addressing mammography's limitations in dense breast tissue. The test achieved 92.3 ...
As the diagnostic landscape evolves, several patterns are emerging across both clinical research and market innovation.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback